NL7413642A - Werkwijze voor de bereiding van een virus subeenheid vaccin. - Google Patents

Werkwijze voor de bereiding van een virus subeenheid vaccin.

Info

Publication number
NL7413642A
NL7413642A NL7413642A NL7413642A NL7413642A NL 7413642 A NL7413642 A NL 7413642A NL 7413642 A NL7413642 A NL 7413642A NL 7413642 A NL7413642 A NL 7413642A NL 7413642 A NL7413642 A NL 7413642A
Authority
NL
Netherlands
Prior art keywords
preparation
subunit vaccine
virus subunit
virus
vaccine
Prior art date
Application number
NL7413642A
Other languages
English (en)
Other versions
NL181553C (nl
NL181553B (nl
Original Assignee
Flockhart & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flockhart & Co filed Critical Flockhart & Co
Publication of NL7413642A publication Critical patent/NL7413642A/nl
Publication of NL181553B publication Critical patent/NL181553B/nl
Application granted granted Critical
Publication of NL181553C publication Critical patent/NL181553C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17Newcastle disease virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18151Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NLAANVRAGE7413642,A 1973-10-18 1974-10-17 Werkwijze voor de bereiding van een virus-subeenheid-vaccin. NL181553C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB48685/73A GB1486557A (en) 1973-10-18 1973-10-18 Process for the preparation of pyrogen-free sub-unit vaccine

Publications (3)

Publication Number Publication Date
NL7413642A true NL7413642A (nl) 1975-04-22
NL181553B NL181553B (nl) 1987-04-16
NL181553C NL181553C (nl) 1987-09-16

Family

ID=10449549

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7413642,A NL181553C (nl) 1973-10-18 1974-10-17 Werkwijze voor de bereiding van een virus-subeenheid-vaccin.

Country Status (15)

Country Link
JP (1) JPS5082228A (nl)
AT (1) AT334524B (nl)
BE (1) BE821175A (nl)
CA (1) CA1050886A (nl)
CH (1) CH611518A5 (nl)
DE (1) DE2449530C2 (nl)
DK (1) DK138581B (nl)
FR (1) FR2248054B1 (nl)
GB (1) GB1486557A (nl)
IE (1) IE40187B1 (nl)
IL (1) IL45870A (nl)
NL (1) NL181553C (nl)
NO (1) NO142024C (nl)
SE (1) SE426439B (nl)
ZA (1) ZA746398B (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK276380A (da) * 1979-07-09 1981-01-10 Univ Iowa State Res Found Inc Fremgangsmaade til fremstilling af en vaccine mod infektioes kvaeg-rhinotracheitis
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
FR2475572A1 (fr) * 1980-02-11 1981-08-14 Pasteur Institut Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
FR2483779A1 (fr) 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
CZ2003930A3 (cs) * 2000-10-02 2003-08-13 Glaxosmithkline Biologicals S. A. Vakcinační prostředek obsahující štěpený virus s obalem

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
ATA835074A (de) 1976-05-15
SE426439B (sv) 1983-01-24
SE7413113L (nl) 1975-04-21
FR2248054B1 (nl) 1978-07-28
BE821175A (fr) 1975-04-17
NO142024B (no) 1980-03-10
IE40187L (en) 1975-04-18
DK138581B (da) 1978-10-02
AU7444974A (en) 1976-04-29
AT334524B (de) 1976-01-25
NO142024C (no) 1980-06-18
IL45870A0 (en) 1974-12-31
NO743758L (nl) 1975-05-12
IL45870A (en) 1978-03-10
DE2449530A1 (de) 1975-04-30
DE2449530C2 (de) 1985-08-08
CH611518A5 (en) 1979-06-15
DK543974A (nl) 1975-06-16
ZA746398B (en) 1976-06-30
IE40187B1 (en) 1979-03-28
NL181553C (nl) 1987-09-16
NL181553B (nl) 1987-04-16
DK138581C (nl) 1979-03-12
JPS5082228A (nl) 1975-07-03
CA1050886A (en) 1979-03-20
FR2248054A1 (nl) 1975-05-16
GB1486557A (en) 1977-09-21

Similar Documents

Publication Publication Date Title
NL7507798A (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat.
NL7413855A (nl) Werkwijze voor het bereiden van een vaccin en van hulpmiddelen die dit vaccin bevatten.
NL182369C (nl) Werkwijze voor het bereiden van een oraal geneesmiddelpreparaat met verlengde afgifte.
NL7506407A (nl) Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.
NL7607902A (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat.
NL7604429A (nl) Werkwijze voor het bereiden van een hepatitis b vaccin.
NL7411312A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL7502808A (nl) Werkwijze ter bereiding van een preparaat voor de behandeling van mastitis.
NL7412747A (nl) Werkwijze voor de bereiding van een genees- l met gestagene werking.
NL7601114A (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat.
NL7504216A (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat.
NL189050C (nl) Werkwijze voor het bereiden van een hepatitis-a-antigeen bevattend preparaat en werkwijze voor het bereiden van een vaccin tegen hepatitis-a.
NL7510120A (nl) Werkwijze voor de bereiding van een vaccin tegen ingewandsstoornissen.
NL7413642A (nl) Werkwijze voor de bereiding van een virus subeenheid vaccin.
NL7513064A (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat.
NL185824C (nl) Werkwijze voor de bereiding van een farmaceutische doseringseenheid.
NL159580B (nl) Werkwijze ter bereiding van een farmaceutisch preparaat.
NL7501680A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL177079C (nl) Werkwijze voor het bereiden van een colibacillosis vaccin.
NL7506872A (nl) Werkwijze voor de bereiding van een farmaceutische preparaat.
NL7602413A (nl) Werkwijze voor het bereiden van een vaccin.
NL7601423A (nl) Werkwijze voor de bereiding van een farmaceu- tisch preparaat.
NL7413323A (nl) Werkwijze voor de bereiding van een veterinair preparaat.
NL188982C (nl) Werkwijze voor het bereiden van een vaccin tegen hepatitis a.
NL179542C (nl) Werkwijze voor de bereiding van een anthelmintisch preparaat.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
SNR Assignments of patents or rights arising from examined patent applications

Owner name: EVANS MEDICAL LIMITED

V4 Discontinued because of reaching the maximum lifetime of a patent